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Abstract
Background: A computational model of myocardial energy metabolism was used to assess the metabolic
responses to normal and reduced myocardial blood flow. The goal was to examine to what extent glycolysis and
lactate formation are controlled by the supply of glycolytic substrate and/or the cellular redox (NADH/NAD+)
and phosphorylation (ATP/ADP) states.
Methods: Flow was reduced over a wide range and for a sufficient duration in order to investigate the sequence
of events that occur during the transition to a new metabolic steady state.
Results:  Simulation results indicated multiple time-dependent controls over both glycolysis and lactate
formation.
Conclusions: Changes in phosphorylation state and glucose uptake only significantly affect the initial phase of the
glycolytic response to ischemia, while glycogen breakdown exerts control over glycolysis during the entire
duration of ischemia. Similarly, changes in the redox state affect the rates of lactate formation and release
primarily during the initial transient phase of the response to the reductions in blood flow, while the rate of
glycolysis controls the rate of lactate formation throughout the entire period of adaptation.
Background
The primary effect of reduced myocardial blood flow is a
decrease in the rate of aerobic ATP resynthesis, an increase
in the cellular redox state (NADH/NAD+), acceleration of
glycogenolysis and glycolysis, accumulation of lactate,
and a switch from net lactate uptake to net lactate release
by the myocardium. Studies in pigs and dogs have shown
that the extent of the metabolic derangement (e.g.,
increased glycolytic rate and lactate production) during
reduced myocardial blood flow is dependent upon the
severity and duration of flow reduction [1-6]. Glucose
uptake increases during moderate ischemia, but decreases
in severely ischemic myocardium due to limited glucose
delivery [7,8], causing a greater reliance on glycogen for
glycolytic substrate. The classic switch to net lactate release
with the onset of reduced myocardial blood flow (30–
50% reduction) gradually reverses back to no net lactate
exchange after 40 to 120 minutes [9]. The control mecha-
nisms responsible for the gradual reduction in lactate
release are unclear.
At a given demand, O2 delivery to the myocardium deter-
mines the rate of oxidative phosphorylation, which sets
the cellular NADH/NAD+ and ATP/ADP ratios, both of
which control the rate of glycolysis and lactate formation
[10]. Ischemia results in impaired oxidative
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phosphorylation and a decrease in the ATP/ADP and
phosphocreatine/creatine (PCr/Cr) ratios, which acceler-
ate ATP formation by glycolysis. The rate of glycolysis is
also dependent upon substrate supply (i.e., myocardial
glycogen concentration and the uptake of exogenous glu-
cose) [11]. It is unclear to what extent the rates of glycoly-
sis and lactate formation, in the transition from normal to
ischemic conditions, are controlled by the supply of glyc-
olytic substrate or the cellular redox and phosphorylation
states (NADH/NAD+ and ATP/ADP). Dynamic informa-
tion characterizing some of the mechanisms that control
the rate of glycolysis could be obtained from examination
of transient metabolic responses to sudden reductions in
myocardial blood flow of various magnitudes and dura-
tions. However, relevant in vivo studies examining the
inter-regulation of oxidative and glycolytic metabolism
during the normal-to-reduced flow transition have not
been performed over a wide range of myocardial blood
flows during prolonged periods of ischemia. Moreover, it
is extremely difficult to continuously measure key meta-
bolic processes in vivo with current experimental tech-
niques, especially during the first few minutes of this
transition. In particular, tissue biopsies are taken at least
10 minutes after the onset of ischemia, which is already
past the period when dynamics changes occur. The char-
acteristics of metabolic control mechanisms, typically elu-
cidated during the transients, are then unattainable. An
alternative approach to animal or human experimenta-
tion is to use computational models to predict the meta-
bolic responses and to analyze covariations in the
dynamics of key concentrations and flux rates and their
interdependence at various degrees of ischemia [12-16].
We recently developed a computational model of cardiac
metabolism for large mammals [17]. The model was vali-
dated under steady-state conditions with normal and
reduced myocardial flow (60% reduction). Specifically,
the model predicted changes in (1) lactate, glycogen,
acetyl-CoA, CoA, ATP, and PCr concentrations, (2) glu-
cose, fatty acid, and lactate uptakes, and (3) contribution
of fatty acids and carbohydrates to acetyl-CoA formation
and was validated with published experimental data pre-
and post-induction of moderate ischemia. Unfortunately,
to date, it has not been possible to validate the transient
changes in fluxes and concentrations due to lack of appro-
priate in vivo experimental data. The main goal of the
present investigation was to determine to what extent gly-
colysis and lactate formation, in the transition from nor-
mal to ischemic conditions, are regulated by the fluxes
supplying glycolytic substrate or the cellular redox and
phosphorylation states. To accomplish this, we extended
our previous model and simulated the metabolic
responses to step decreases in blood flow in order to
examine the transition to a new metabolic steady state.
Specifically, computer simulations of the metabolic
responses to myocardial blood flow reductions of varying
degrees and durations were performed to investigate the
dynamics of key metabolite concentrations and fluxes
from the onset of ischemia out to 6 hours.
Methods
To quantitatively investigate the effects of magnitude and
duration of a reduction in myocardial blood flow on car-
diac metabolism, we made some modifications to our
previous computational model [17] and simulated the
metabolic responses to a wide range of blood flow reduc-
tions (from mild to very low-flow ischemia). Presented in
this work are the metabolic responses to various graded
reductions in myocardial blood flow (MBF), focusing on
the substrate concentrations and fluxes related to pyruvate
metabolism (Fig. 1). The model consists of a set of inter-
dependent dynamic mass balance equations, one for each
species included. The general form of the mass balance
(equation 1), shown for species j, is described by:
where all terms are normalized per amount of tissue
under the assumption that the density of both tissue and
blood are 1 g ml-1. Here Pj* and Uj* are the specific rates
of production and utilization of species j. The last term on
the right side represents the tissue-blood exchange where
MBF is the specific blood flow to the heart, σj is the blood-
tissue partition coefficient, and Ca, j is the arterial blood
concentration. In this single organ model, the arterial con-
centrations are assumed to remain constant since the rel-
ative contribution of the cardiac venous effluent to the
pool of the metabolites present in the blood is very small,
even during ischemia, as evidenced by in vivo experimen-
tal preparations [18,19]. The production and utilization
rates of each species depend on all of the reactions
included in the model that result in the formation or con-
sumption of the species, respectively, and are determined
from reaction fluxes with appropriate stoichiometric coef-
ficients (βkj) where p refers to the reaction process (equa-
tion 2).
In the current model, the effective-volume coefficient is
eliminated by normalizing concentrations and flux rates.
In addition, the flux rates (Φkj) are expressed as Michaelis-
Menten functions of the reactant concentration, Ck,
instead of following first-order kinetics as presented previ-
ously [17]:
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In the flux expressions, Vkj replaces the rate coefficient, λjk,
of the previous version of the model, and represents the
control exerted by the regulatory metabolites, which
include Cr/PCr, NADH/NAD+, ADP/ATP, and acetyl-CoA/
free-CoA. The specific Vkj representations are presented in
Table 1, where CS = CR/PCr, RS = NADH/NAD+, PS =
ADP/ATP, and AF = acetyl-CoA/free-CoA. The flux rates,
Φkj, are expressed in a Michaelis-Menten form so that the
reaction rates can respond rapidly to small changes in sub-
strate concentrations or regulatory metabolites [20] thus
allowing for feedback in the form of mass action (Table
1). With an increase in the product concentration the flux
involving the formation of that product decreases.
Similarly, with an increase in substrate concentration the
flux increases in the direction of product formation.
In addition, pyruvate exchange between the blood and
myocardium was included in the current model, although
Schematic of metabolic pathways Figure 1
Schematic of metabolic pathways.
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Table 1: Rate Coefficient Expressions
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under normal conditions it is close to zero [19]. Incorpo-
ration of new elements in the previous model resulted in
minor changes in a few "ping-pong" weighting coeffi-
cients, Km values, and rate coefficients (see Table 2). More-
over, the results obtained with the improved model
agreed well with those from the original model when sim-
ulating the metabolic response to a 60% reduction in
myocardial blood flow [17].
Computer simulations (in silico experiments) of the meta-
bolic responses to reduced myocardial blood flow
(parameter MBF) were performed by solving the model
equations using an implicit integrator, LSODES [21]. Sim-
ulation results from these parametric studies enable us to
analyze the effects of myocardial ischemia of various
degrees and durations. Experimentally, the extent of
ischemia can be controlled by using an external circuit
with a pump or an occlusion device on the left anterior
descending coronary artery. In both cases, oxygen delivery
to the myocardium is proportionate to the reduction in
blood flow. In the present investigation, we used our com-
putational model to simulate the metabolic responses to
myocardial ischemia of various degrees. The severity of
ischemia was set by reducing myocardial blood flow
(MBF*) from its normal value 1.0 ml g-1 min-1 to 0.1 ml g-
1 min-1 in 0.1 ml g-1 min-1 decrements. The reduction from
normal to reduced blood flow was implemented expo-
nentially over 1 min. Due to methodological limitations,
scarce data have been collected during the first few min-
utes and after 90 minutes of myocardial ischemia in in
vivo animal models, therefore we ran the simulations out
to 6 hours.
Since our overall goal was to investigate the regulation of
glycolysis and lactate formation at the onset of ischemia
and during the transition to a new metabolic steady state,
we simulated the time profiles of (a) myocardial ATP, PCr,
NADH, NAD+, glycogen, pyruvate and lactate concentra-
tions, (b) the rates of glucose, lactate, and oxygen uptake,
and (c) the rates of glycolysis, lactate production, and
pyruvate oxidation and focused our analysis on the early
and late phases of the acute response to reduced blood
flow. The transient responses were analyzed using non-
linear regression analysis to characterize the time profiles
of the concentrations and flux rates changes due to
ischemia. Response times (τ) were estimated from this
analysis as the time it took to reach ~63% of the steady
state response change.
Results
Transient responses to myocardial blood flow reductions
The metabolic responses to reduced myocardial blood
flow were evaluated by performing a series of computer
simulations, each corresponding to a specific reduction in
myocardial blood flow. Accordingly, myocardial blood
flow was reduced from its normal value of 1.0 to 0.1 ml g-
1 min-1in 10% decrements. For clarity, we only show the
responses for myocardial blood flows of 0.8, 0.6, 0.4, 0.2
and 0.1 ml g-1 min-1.
Table 2: Changes in Parameter Values
Flux (µmol g-1 min-1)
φCR→PC 4.55
φPC→CR 4.55
Rate Coefficients (min-1)
Vmax, GL→GP 0.492
Vmax, FA→TG 0.24
Vmax, FA→AC 0.944
Vmax, GP→PY 5.28
Vmax, GP→GY 1.6
Vmax, GY→GP 1.6
Vmax, TG→FA 0.08
Vmax, PY→LA 3.96
Vmax, PY→AC 5.04
Vmax, LA→PY 3.84
Vmax, AC→CO2 6.4
Vmax, 02→H20 5.63
Vmax, CR→PC 100
Vmax, PC→CR 100
Vmax, AC→CoAPool 0.247
Vmax, CoAPool→FC 0.051
Vmax, ATPhydrolysis 34.9
Km Values (µmol g-1)
Km, GL→GP 0.025
Km, FA→TG 0.0245
Km, FA→AC 0.0245
Km, GP→PY 1.7
Km, GP→GY 0.17
Km, GY→GP 33
Km, TG→FA 4
Km, PY→LA 2
Km, PY→AC 0.2
Km, LA→PY 2
Km, AC→CO2 0.0046
Km, 02→H20 0.01
Km, CR→PC 88
Km, PC→CR 88
Km, AC→CoAPool 0.0046
Km, CoAPool→FC 0.043
Weighting Coefficients
εGP→PY eliminated
εGP→GY 0.75
εGY→GP 0.75
εPY→AC 0.75
εAC→CO2 0.7BioMedical Engineering OnLine 2004, 3 http://www.biomedical-engineering-online.com/content/3/1/15
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Flow reductions smaller than 0.2 ml g-1 min-1 from nor-
mal myocardial blood flow did not alter myocardial oxy-
gen consumption (MVO2) but resulted in small decreases
(<4%) in ATP and PCr concentrations, and moderate
increases (<10%) in NADH/NAD+. Larger reductions in
myocardial blood flow resulted in a rapid exponential
decrease in MVO2 with τ ranging from 0.4 min at a flow of
0.1 ml g-1 min-1 to 0.9 min at a flow of 0.7 ml g-1 min-1
(Fig. 2A). The drop in MVO2 to new steady-state values
was proportional to the degree of flow reduction, which
has also been shown experimentally [22].
The redox state increased almost as rapidly as MVO2
decreased with τ ranging from 0.6 min at a flow of 0.1 ml
g-1 min-1 to 2.4 min at a flow of 0.7 ml g-1 min-1. Flow
reductions beyond 0.8 ml g-1 min-1 also caused rapid
increases in NADH content (concentration ratio of
NADH/(NADH + NAD+)) and a rapid fall in ATP (τ rang-
ing from 0.7 min at a flow of 0.1 ml g-1 min-1 to 1.9 min
at a flow of 0.8 ml g-1 min-1) to stable levels that were pro-
portional to the fall in MVO2 (Figs. 2B and 2D). Phospho-
creatine concentration fell less rapidly than ATP
concentration (τ ranging from 1.5 min at a flow of 0.1 ml
g-1 min-1 to 3.0 min at a flow of 0.8 ml g-1 min-1) and
reached steady-state values nonlinearly related to the fall
in MVO2 (Fig. 2C).
Lactate concentration and the lactate to pyruvate ratio
(LA/PY) displayed a biphasic behavior in response to flow
reductions beyond 0.8 ml g-1  min-1. Flow reductions
caused a large (up to 26 µmol g-1) but slow (τ ranging
from 15 min at a flow of 0.8 ml g-1 min-1 to 38 min at a
flow of 0.1 ml g-1 min-1) transient increase in lactate con-
centration followed by a slow exponential decrease
toward steady-state levels (Fig. 2E) and a rapid decrease in
LA/PY followed by a nonlinear increase toward steady-
state values proportional to the reduction in myocardial
blood flow (Fig. 2F).
The rate of glucose uptake decreased by half immediately
(~24 sec) after the onset of blood flow reduction and then
increased rapidly (1.3 min <τ <1.9 min) toward steady
state, with a peak rate at a flow of 0.2 ml g-1 min-1, and
lower steady state values at a flow of 0.1 ml g-1 min-1 (Fig.
3A). The net rate of glycogen breakdown reached a peak
after 5 to 7 minutes of flow reduction, and gradually
returned toward zero by 120 to 180 minutes, and did not
change out to 6 hours (Fig. 3B). The rate of glycolysis
increased rapidly (τ ranging from 1.7 min at a flow of 0.1
ml g-1 min-1 to 5.8 min at a flow of 0.8 ml g-1 min-1) with
the onset of flow reduction, peaking between 5 and 10
minutes after the onset, and then declined gradually up to
~180 minutes (Fig. 3C) as glycogen stores were depleted.
The contribution of glycogen breakdown to the total rate
of glycolysis over the initial 90 minutes was greater with
more severe flow reduction. After approximately 120 min-
utes of ischemia net glycogen breakdown was minimal
and glucose uptake was the primary provider of glycolytic
substrate (Figs. 3A and 3B).
Under normal flow conditions there is net lactate uptake
(i.e., a negative net lactate release) and a net rate of lactate
oxidation by the heart. Simulation results indicated that
in the early transient phase, net lactate release increased in
proportion to the severity of the reduction in myocardial
blood flow, with a peak effect ~13–28 minutes after the
onset of flow reduction. Then, net lactate release
decreased exponentially toward steady levels, which were
reached after approximately 150 minutes of flow reduc-
tion (Fig. 3D). The rate of lactate production increased at
a faster rate (peak at ~7.5 min after the onset of flow
reduction) than the rate of lactate release, and was larger
than the rate of lactate utilization at myocardial blood
flows lower than 0.7 ml g-1 min-1 resulting in net lactate
production and lactate release.
Metabolic changes as a function of myocardial blood flow
To determine to what extent the rate of glycolysis and lac-
tate formation in the transition from normal to ischemic
conditions are controlled by the supply of glycolytic sub-
strate or the cellular redox and phosphorylation states, we
examined the ischemia-induced changes in key concentra-
tions and fluxes as a function of myocardial blood flow.
Figures 4 and 5 are plots of the metabolic data as a func-
tion of myocardial blood flow during the early phase (at
7 min) and after 30, 90 and 180 minutes of flow
reduction.
Myocardial oxygen consumption remained constant
when blood flow was reduced from 1.0 to 0.9 ml g-1 min-
1 but decreased linearly with blood flow reductions from
0.8 to 0.1 ml g-1 min-1 (Fig. 4A). The concentration ratio of
NADH/(NADH + NAD+) increased exponentially as myo-
cardial blood flow was reduced and oxygen consumption
fell; NADH concentration values after 7 minutes of the
onset of blood flow reduction were larger than those after
the steady state was reached (~180 min) only when myo-
cardial blood flow was between 0.2 and 0.6 ml g-1 min-1
(Fig. 4B). Myocardial ATP content did not change (< 1%)
from its initial value when flow was decreased from 1 to
0.9 ml g-1 min-1, but it fell as a linear function of blood
flow from 0.8 to 0.1 ml g-1 min-1 (Fig. 4C). On the other
hand, phosphocreatine (PCr) content changed slightly
(<4%) when flow was reduced from 1.0 to 0.9 ml g-1 min-
1, but decreased exponentially to nearly zero when myo-
cardial blood flow was reduced from 0.8 to 0.1 ml g-1 min-
1, reflecting its role as a "buffer" for ATP during the transi-
tion to reduced myocardial blood flow (Fig. 4D). Lactate
concentration in the tissue increased exponentially with
myocardial blood flow reduction, with the largest increaseBioMedical Engineering OnLine 2004, 3 http://www.biomedical-engineering-online.com/content/3/1/15
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Time courses of myocardial (A) oxygen consumption (MVO2), (B) ATP concentration, (C) phosphocreatine concentration, (D)  the concentration ratio of NADH/(NADH + NAD+), (E) lactate concentration, and (F) lactate to pyruvate ratio (LA/PY) from  computer simulations of reductions (0.8, 0.6, 0.4, 0.2, and 0.1 ml/g/min) in myocardial blood flow Figure 2
Time courses of myocardial (A) oxygen consumption (MVO2), (B) ATP concentration, (C) phosphocreatine concentration, (D) 
the concentration ratio of NADH/(NADH + NAD+), (E) lactate concentration, and (F) lactate to pyruvate ratio (LA/PY) from 
computer simulations of reductions (0.8, 0.6, 0.4, 0.2, and 0.1 ml/g/min) in myocardial blood flow.
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occurring after ~30 min of the onset of flow reduction; lac-
tate concentration decreased gradually thereafter, reach-
ing a stable concentration by 180 minutes of flow
reduction (Fig. 4E). The tissue lactate to pyruvate ratio did
not change when blood flow was reduced from 1.0 to 0.8
ml g-1 min-1, but increased nonlinearly with myocardial
blood flow reductions from 0.7 to 0.1 ml g-1 min-1. This
ratio kept increasing after 30 minutes of the onset of flow
reduction, and reaching a steady value by 180 minutes
(Fig. 4F).
The net rate of glycogen breakdown increased nonlinearly
with myocardial blood flow reductions from 0.8 to 0.1 ml
g-1 min-1 after 7 and 30 minutes of the onset of flow reduc-
tion, while it only displayed a small increase followed by
a gradual decrease after 90 minutes (Fig. 5A), reflecting
the effects of glycogen depletion early in the ischemic
period. The rate of glucose uptake increased nonlinearly
with blood flow reduction, reaching a plateau 1.8-fold
above its normal value at 0.2 ml g-1 min-1. The rate of
glucose uptake fell modestly when flow was further
reduced to 0.1 ml g-1 min-1 (Fig. 5B).
Under normal aerobic conditions there was simultaneous
conversion of lactate to pyruvate and pyruvate to lactate in
the myocardium with net lactate uptake from the blood.
Dynamics of the myocardial rates of (A) exogenous glucose uptake, (B) net glycogen breakdown, (C) glycolysis, and (D) net  lactate release obtained from computer simulations of reductions (0.8, 0.6, 0.4, 0.2, and 0.1 ml/g/min) in myocardial blood flow Figure 3
Dynamics of the myocardial rates of (A) exogenous glucose uptake, (B) net glycogen breakdown, (C) glycolysis, and (D) net 
lactate release obtained from computer simulations of reductions (0.8, 0.6, 0.4, 0.2, and 0.1 ml/g/min) in myocardial blood flow.
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Computer-simulated values for myocardial (A) MVO2, (B) the concentration ratio of NADH/(NADH + NAD+), (C) ATP con- centration, (D) phosphocreatine concentration, (E) lactate concentration, and (F) lactate to pyruvate ratio (LA/PY) after 7, 30,  90, and 180 minutes of the onset of flow reduction plotted as a function of the myocardial blood flow Figure 4
Computer-simulated values for myocardial (A) MVO2, (B) the concentration ratio of NADH/(NADH + NAD+), (C) ATP con-
centration, (D) phosphocreatine concentration, (E) lactate concentration, and (F) lactate to pyruvate ratio (LA/PY) after 7, 30, 
90, and 180 minutes of the onset of flow reduction plotted as a function of the myocardial blood flow.
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Computer-simulated values for myocardial rates of (A) net glycogen breakdown, (B) exogenous glucose uptake, (C) conversion  of lactate to pyruvate, (D) pyruvate oxidation (conversion of pyruvate to acetyl-CoA), (E) conversion of pyruvate to lactate,  and (F) net lactate release after 7, 30, 90, and 180 minutes of the onset of flow reduction plotted as a function of the myocar- dial blood flow Figure 5
Computer-simulated values for myocardial rates of (A) net glycogen breakdown, (B) exogenous glucose uptake, (C) conversion 
of lactate to pyruvate, (D) pyruvate oxidation (conversion of pyruvate to acetyl-CoA), (E) conversion of pyruvate to lactate, 
and (F) net lactate release after 7, 30, 90, and 180 minutes of the onset of flow reduction plotted as a function of the myocar-
dial blood flow.
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The rate of lactate conversion to pyruvate decreased line-
arly from 0.85 to 0.15 µmol g-1 min-1 with blood flow
reductions from 0.8 to 0.3 ml g-1 min-1, and was effectively
zero with flows of 0.2 ml g-1 min-1 and less (Fig. 5C). On
the other hand, the rate of pyruvate conversion to lactate
increased linearly with myocardial blood flow reductions
below 0.8 ml g-1 min-1, with a peak effect at ~7.5 minutes,
and a progressive fall over 90 minutes, reaching stable val-
ues at 180 minutes (Fig. 5E). The net lactate release by the
myocardium was negative under normal flow conditions,
did not change much at flows of 0.9 and 0.8 ml g-1 min-1,
and increased progressively with flows between 0.8 and
0.1 ml g-1 min-1 (Fig. 5F). The slope in the relationship
between net lactate production and myocardial blood
flow fell progressively from 7.5 minutes to 180 minutes
and then remained constant out to 6 hours. The rate of
pyruvate oxidation to acetyl-CoA decreased linearly with
blood flow reductions between 0.7 and 0.1 ml g-1 min-1
(Fig. 5D).
The rate of glycolysis increased nonlinearly with myocar-
dial blood flow reduction, and reached a plateau with
flows between 0.3 and 0.2 ml g-1 min-1 after 7 and 30
minutes of the onset of flow reduction and between 0.6
and 0.2 ml g-1 min-1 after 90 minutes (Fig. 4C).
Discussion
Computer simulations of the transition from normal to
reduced myocardial blood flow were used to study
covariations between the rates of glycolysis and lactate
formation and (1) the concentrations of NADH, NAD,
ADP, and ATP and (2) the rates of glycogen breakdown
and glucose uptake in order to elucidate mechanisms reg-
ulating anaerobic glycolysis in ischemic myocardium.
Consequently, the time courses of the various processes
affecting glycolysis and lactate dynamics from the onset of
flow reduction and up to six hours later were computed
and characterized for decreasing values of myocardial
blood flow. Our results show that the glycolytic rate dur-
ing the transition to reduced myocardial flow is regulated
by glycogen breakdown, glucose uptake, ATP/ADP, and
PCr/Cr. Two distinct mechanisms regulating myocardial
lactate dynamics during flow reduction became apparent:
(1) control by the redox state immediately after the onset
of flow reduction and (2) control of glycolysis by sub-
strate availability (i.e., glycogen) through the transition to
a new steady state.
Control of glycolysis during reduced myocardial blood flow
Examination of simulations show the crucial role of (1)
ATP/ADP and PCr/Cr in the burst of glycolytic rate with
the initiation of ischemia, and (2) glycolytic substrate
supply in the later phase of the ischemic response. The
time courses of ATP and PCr indicate that these metabo-
lites contribute to the initial increase in the rates of glyco-
lysis and glycogenolysis, respectively. Our model-
simulated results predicted PCr concentration falling less
rapidly than ATP concentration, showing a sluggish
response of PCr in buffering ATP. It is difficult to validate
this prediction with experimental data from human-like
animals, as limited data exists on the dynamic changes of
ATP and PCr. Most data collected from these animal
experiments have been collected after 5 minutes of the
introduction of ischemia. The only studies that measured
PCr and ATP using an in vivo preparation, showed
decreases in both after 5 min of ischemia and while there
were then no significant changes in ATP concentration
after 5 min the results showed a regeneration of PCr after
5 min [1,3]. It is clear from these results that more infor-
mation on the dynamic changes of PCr and ATP concen-
trations is necessary in order to get a clear picture of their
dynamic changes. However, given the known
characteristics of the creatine kinase reaction [23] and the
observed PCr and ATP dynamic responses from NMR
studies in cardiac and skeletal muscle, it is apparent that
the response time of PCr breakdown should have been
smaller than that of ATP. Experimental studies by Gus-
tafson and Kroll, using an isolated perfused rabbit heart
subjected to a 95% reduction in flow [23,24], showed that
PCr decreased much quicker than ATP while their
decreases (75–78% and 46% for PCr and ATP, respec-
tively) were much lower than our model predicts (96%
and 86%). Therefore, our model, in its current form, does
not appropriately represent the creatine kinase reaction
and is unable to accurately predict PCr and ATP time
courses at the onset of ischemia (0 – 5 min).
A plausible reason for the sluggishness in the PCr
response to ischemia could be related to the ADP source
in the model. Myocardial tissue biopsies taken from in
vivo whole animal preparations are analyzed for total ADP
concentration, which includes bound and free ADP. Since
free ADP, instead of total ADP, participates in the control
of myocardial respiration and glycogenolysis, future ver-
sions of this model should incorporate free ADP. As of
today, we can only derive free ADP concentration from
magnetic resonance spectroscopy data which are difficult
to obtain in large animal in vivo preparations.
In the model, changes in ATP and PCr, mainly determine
the initial direction of the change in fluxes via feedback,
and to a lesser extent the magnitude of the changes in the
rates of glycolysis and glycogenolysis. Lower ATP/ADP
and PCr/Cr values than those found under normal flow
conditions result in higher glycolytic and glycogenolytic
flux rates, while higher ATP/ADP and PCr/Cr values have
the opposite effect. The magnitude of the increase in the
glycolytic rate though, depends primarily on the net rate
of glycogen breakdown and to a lesser extent on glucose
uptake and reduced ATP/ADP and PCr/Cr values. The rateBioMedical Engineering OnLine 2004, 3 http://www.biomedical-engineering-online.com/content/3/1/15
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of glycogen breakdown increases several fold immediately
after the onset of flow reduction increases up to ~2-fold.
The ATP/ADP and PCr/Cr ratios decreased almost imme-
diately after the onset of flow reduction and remained
constant thereafter. Analysis of the time profiles of the
covariations of the glycolytic rate and the above men-
tioned factors suggests that all contribute to the increase
in glycolysis during the early transient phase following
flow reduction; however, only glycogen breakdown seems
to control the rate of glycolysis beyond 10 minutes.
Control of lactate production and release during reduced 
myocardial blood flow
Simulated metabolic responses showed a rapid increase in
the rate of lactate production, at the onset of flow reduc-
tion, which declined to a new steady state value after ~90
to 180 min, as previously demonstrated in swine myocar-
dium [9,11]. Our results also indicated that the rate of gly-
colysis was the only flux rate that increased faster than the
rate of lactate production. The redox state (NADH/NAD+)
also changed fast enough to contribute to the large
increase in lactate production. However, after the initial
phase following the onset of flow reduction, both the
rates of lactate production and glycolysis decreased grad-
ually as linear functions of time while the redox state
remained almost constant or decreased very slowly. The
rates of glycolysis and net lactate release increased sharply
in a flow dependent manner with the onset of flow reduc-
tion, and gradually returned to new steady-state values
after 90 minutes. In contrast, the concentration ratio of
NADH/(NADH + NAD+) increased sharply when flow
was decreased, and remained elevated thereafter (Fig.
2D). Thus, the transient burst of lactate production at the
onset of flow reduction was primarily the result of a rapid
acceleration of glycolysis and, an increase in the cellular
redox state which was mainly determined by the drop in
MVO2. The fall in the rates of glycolysis and lactate pro-
duction from 15–120 minutes was not due to changes in
redox or phosphorylation state, but rather to glycogen
depletion and a switch to dependence on exogenous glu-
cose for glycolytic substrate.
In our model, the fall in myocardial blood flow and oxy-
gen consumption result in a decrease in ATP and PCr con-
centrations, which activate glycogenolysis, glycolysis, and
glycolytic pyruvate formation [17]. Although the intracel-
lular regulation of glycogenolysis occurs by way of Pi in
our model the ratio of PCr/Cr is used as a regulator,
instead of Pi. Because Pi is not explicitly considered in this
version of the model, the PCr/Cr ratio is the best current
approximation of Pi. Future models should incorporate Pi
to describe more accurately this regulation process.
The decrease in MVO2 with ischemia results in a parallel
decrease in redox state which remains relatively constant
throughout the remainder ischemia (Fig. 5D). The
decrease in pyruvate oxidation, on the other hand, is not
in parallel with the decrease in MVO2 due to the sudden
increase in glycolytically-derived pyruvate formation dur-
ing the first few minutes of ischemia (Figs. 4A and 5D).
This suggests that once MVO2 is reduced due to underper-
fusion, the redox state increases rapidly to control the rel-
ative proportion of NADH that is oxidized via lactate
formation or oxidative phosphorylation (Figs. 2A,2B). A
redox shift towards reduction, in the presence of insuffi-
cient blood flow and increased glycolysis, would either
decrease the rate of pyruvate conversion to acetyl-CoA or
keep it constant (Fig. 5D), thus increasing the rate of lac-
tate production (Fig. 5E). Therefore, while the extent of
lactate or water formation coupled to NADH oxidation is
mainly determined by the redox state right after the onset
of flow reduction, the magnitude of the increase in lactate
production with ischemia is mainly determined by the
rate of glycolysis throughout the entire period of flow
reduction.
In this model we used a top-down approach which
focuses on integration and incorporation of those ele-
ments which are essential in predicting the metabolic
responses to ischemia. Accordingly, at the initial stages of
modeling cardiac metabolism, only key physiological
aspects were included to reduce complexity and allow
comparison with available in vivo data. As appropriate
experimental data on dynamic responses become availa-
ble, future models will incorporate additional elements as
needed for testing hypotheses on the regulation of myo-
cardial metabolism during stresses.
Conclusion
In summary, in silico studies were performed using a pre-
viously validated computational model of cardiac
metabolism to examine the extent that glycolysis and lac-
tate formation are controlled by the supply of glycolytic
substrate and/or the cellular redox and phosphorylation
states during the transition from normal to reduced blood
flow conditions. Our results show that multiple time-
dependent mechanisms regulate the rates of glycolysis
and lactate formation. Changes in phosphorylation state
and glucose uptake affect primarily the initial phase of the
glycolytic adaptation to ischemia, while glycogen break-
down exerts the main control over glycolysis during both
the early transient phase and the late adaptation to
ischemia. Similarly, changes in the redox state affect the
rates of lactate formation and release primarily during the
initial transient phase of the response to reductions in
blood flow, while the rate of glycolysis controls the rate of
lactate formation throughout the entire period of
adaptation.BioMedical Engineering OnLine 2004, 3 http://www.biomedical-engineering-online.com/content/3/1/15
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List of Abbreviations
GL Glucose
FA Fatty Acid
GP Glucose-6-Phosphate
GY Glycogen
TG Triglyceride
PY Pyruvate
LA Lactate
AC Acetyl-CoA
FC Free-CoA
O2 Oxygen
CO2 Carbon Dioxide
NAD+  Nicotinamide Adenine Dinucleotide (oxidized
form)
NADH Nicotinamide Adenine Dinucleotide (reduced
form)
AMP Adenosine Monophosphate
ADP Adenosine Diphosphate
ATP Adenosine Triphosphate
Pi Inorganic Phosphate
Cr Creatine
PCr Phosphocreatine
Vj Effective Volume
Caj Arterial Concentration of Species j
σj Blood-Tissue Partition Coefficient for species j
Cj Species j Concentration
LAD Left Anterior Descending Coronary Artery
MBF Myocardial Blood flow
MVO2 Myocardial Oxygen Consumption
Km Michaelis-Menten Constant
Vkj Maximal Rate Coefficient
Vmax Michaelis-Menten Maximal Rate Coefficient
ε Weighting Coefficient
AF AC/FC
CS Cr/PCr
RS NADH/NAD+
PS ADP/ATP
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